Molecular Basis of Steroid Action in the Prostate

Por Zhu, Yuan-Shan
Publicado em 2005

5α-Reductase Isozymes in the Prostate

Por Zhu, Yuan-Shan, Sun, Guang-Huan
Publicado em 2005

Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?

Por Deng, Junli, Tang, Jie, Wang, Guo, Zhu, Yuan-Shan
Publicado no Int J Environ Res Public Health (2017)

Inferior myocardial infarction secondary to aortic dissection associated with bicuspid aortic valve

Por Cai, Jingjing, Cao, Yu, Yuan, Hong, Yang, Kan, Zhu, Yuan-Shan
Publicado em 2012

5α-reductase-2 Deficiency’s Effect on Human Fertility

Por Kang, Hey-Joo, Imperato-McGinley, Julianne, Zhu, Yuan-Shan, Rosenwaks, Zev
Publicado em 2014

Elevated phospholipase D activity in androgen-insensitive prostate cancer cells promotes both survival and metastatic phenotypes

Por Utter, Matthew, Chakraborty, Sohag, Goren, Limor, Feuser, Lucas, Zhu, Yuan-Shan, Foster, David A.
Publicado no Cancer Lett (2018)

Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism

Por Cai, Jingjing, Hong, Yuan, Weng, Chunyan, Tan, Chen, Imperato-McGinley, Julianne, Zhu, Yuan-Shan
Publicado em 2011

Androgen actions on endothelium functions and cardiovascular diseases

Por Cai, Jing-Jing, Wen, Juan, Jiang, Wei-Hong, Lin, Jian, Hong, Yuan, Zhu, Yuan-Shan
Publicado no J Geriatr Cardiol (2016)

Inhibition of Aberrant Androgen Receptor Induction of Prostate Specific Antigen Gene Expression, Cell Proliferation and Tumor Growth by 17α-Estradiol in Prostate Cancer

Por Qiao, Yaming, Wang, Lu, Cai, Li-Qun, Tan, Chen, Imperato-McGinley, Julianne, Zhu, Yuan-Shan
Publicado em 2011

Emerging role of long non-coding RNAs in cisplatin resistance

Por Hu, Yang, Zhu, Qiong-Ni, Deng, Jun-Li, Li, Zhi-Xing, Wang, Guo, Zhu, Yuan-Shan
Publicado no Onco Targets Ther (2018)

MALAT1: a potential biomarker in cancer

Por Li, Zhi-Xing, Zhu, Qiong-Ni, Zhang, Hai-Bo, Hu, Yang, Wang, Guo, Zhu, Yuan-Shan
Publicado no Cancer Manag Res (2018)

Differential effects of estrogen receptor ligands on regulation of dihydrotestosterone-induced cell proliferation in endothelial and prostate cancer cells

Por WENG, CHUNYAN, CAI, JINGJING, WEN, JUAN, YUAN, HONG, YANG, KAN, IMPERATO-McGINLEY, JULIANNE, ZHU, YUAN-SHAN
Publicado em 2012

Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR–Cas9 and ssODN in human cancer cells

Por Hu, Zheng, Shi, Zhaoying, Guo, Xiaogang, Jiang, Baishan, Wang, Guo, Luo, Dixian, Chen, Yonglong, Zhu, Yuan-Shan
Publicado no Cell Biosci (2018)

17α-Estradiol Inhibits LAPC-4 Prostatic Tumor Cell Proliferation in Cell Cultures and Tumor Growth in Xenograft Animals

Por Qiao, Yaming, Zhang, Zhi-Kai, Cai, Li-Qun, Tan, Chen, Imperato-McGinley, Julianne L., Zhu, Yuan-Shan
Publicado em 2007

The role of long non-coding RNAs in nasopharyngeal carcinoma: As systemic review

Por He, Rongzhang, Hu, Zheng, Wang, Qingmei, Luo, Weihao, Li, Jia, Duan, Lili, Zhu, Yuan-shan, Luo, Di-xian
Publicado no Oncotarget (2016)

Receptor Isoform and Ligand-Specific Modulation of Dihydrotestosterone-Induced Prostate Specific Antigen Gene Expression and Prostate Tumor Cell Growth by Estrogens

Por ZHU, YUAN-SHAN, CAI, LI-QUN, HUANG, YING, FISH, JASON, WANG, LU, ZHANG, ZHI-KAI, IMPERATO-MCGINLEY, JULIANNE L.
Publicado em 2005

NSC606985, a novel camptothecin analog, induces apoptosis and growth arrest in prostate tumor cells

Por Tan, Chen, Cai, Li-Qun, Wu, Wendy, Qiao, Yaming, Imperato-McGinley, Julianne, Chen, Guo-Qiang, Zhu, Yuan-Shan
Publicado em 2008

Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment

Por Huang, Li, He, Rongzhang, Luo, Weihao, Zhu, Yuan-Shan, Li, Jia, Tan, Tan, Zhang, Xi, Hu, Zheng, Luo, Dixian
Publicado no Recent Pat Anticancer Drug Discov (2016)

Dual action of NSC606985 on cell growth and apoptosis mediated through PKCδ in prostatic cancer cells

Por Wang, Xin, Tan, Chen, Wang, Guo, Cai, Jing-Jing, Wang, Li-Ping, Imperato-McGinley, Julianne, Zhu, Yuan-Shan
Publicado no Int J Oncol (2017)

LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway

Por Zhu, Qiong-Ni, Wang, Guo, Guo, Ying, Peng, Yan, Zhang, Rui, Deng, Jun-Li, Li, Zhi-Xing, Zhu, Yuan-Shan
Publicado no Oncotarget (2017)